FDG PET/CT and Conventional Imaging Methods in Cancer of Unknown Primary: an Approach to Overscanning
- 12 September 2018
- journal article
- research article
- Published by Springer Nature in Nuclear Medicine and Molecular Imaging
- Vol. 52 (6) , 438-444
Abstract
To compare the performance of fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography (FDG PET/CT) with conventional imaging methods (CIM), including computed tomography (CT), magnetic resonance imaging (MRI), and mammography (MMG) in cancer of unknown primary (CUP).Keywords
This publication has 19 references indexed in Scilit:
- Appropriateness criteria of FDG PET/CT in oncologyIndian Journal of Radiology and Imaging, 2015
- Utility of F-18 fluorodeoxyglucose posıtron emıssıon tomography/computed ın carcınoma of unknown primary.2014
- Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primaryCancer Epidemiology, 2012
- A Prospective Comparison of 18F-FDG PET/CT and CT as Diagnostic Tools to Identify the Primary Tumor Site in Patients with Extracervical Carcinoma of Unknown Primary SiteThe Oncologist, 2012
- Carcinoma of unknown primary (CUP)Critical Reviews in Oncology/Hematology, 2009
- Non–Small Cell Lung Cancer: Prospective Comparison of Integrated FDG PET/CT and CT Alone for Preoperative StagingRadiology, 2005
- Unknown Primary Tumors: Detection with Dual-Modality PET/CT—Initial ExperienceRadiology, 2005
- The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumorCancer, 2004
- Whole-Body Dual-Modality PET/CT and Whole-Body MRI for Tumor Staging in OncologyJAMA, 2003
- Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalitiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002